Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan is the major structural component of the *Staphylococcus aureus* cell wall, providing mechanical strength and rigidity while maintaining cellular integrity. It forms a thick three-dimensional mesh that encapsulates the bacterium, protecting it from environmental stresses and contributing to its pathogenicity. Peptidoglycan fragments are recognized by host immune systems as pathogen-associated molecular patterns (PAMPs), triggering inflammatory responses. Its synthesis is targeted by several antibiotics (e.g., β-lactams), but resistance mechanisms complicate treatment strategies.
Inhibition of peptidoglycan synthesis (transpeptidation and/or transglycosylation)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus Peptidoglycan (PGN).